Sirolimus-Based Immunosuppressive Regimens in Renal Transplantation: A Systemic Review
Author:
Funder
Science and Technology Planning Project of Guangdong Province
Publisher
Elsevier BV
Subject
Transplantation,Surgery
Reference70 articles.
1. The side effect profile of sirolimus: a phase I study in quiescent cyclosporine-prednisone-treated renal transplant patients;Murgia;Kidney Int,1996
2. Sirolimus reduces the incidence of acute rejection episodes despite lower cyclosporine doses in caucasian recipients of mismatched primary renal allografts: a phase II trial. Rapamune Study Group;Kahan;Transplantation,1999
3. Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study. The Rapamune US Study Group;Kahan;Lancet,2000
4. A worldwide, phase III, randomized, controlled, safety and efficacy study of a sirolimus/cyclosporine regimen for prevention of acute rejection in recipients of primary mismatched renal allografts;MacDonald;Transplantation,2001
5. Two-year results of multicenter phase III trials on the effect of the addition of sirolimus to cyclosporine-based immunosuppressive regimens in renal transplantation;Kahan;Transplant Proc,2003
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Thermosensitive Hydrogels as Targeted and Controlled Drug Delivery Systems: Potential Applications in Transplantation;Macromolecular Bioscience;2024-07-11
2. Pharmacomicrobiomics: Immunosuppressive Drugs and Microbiome Interactions in Transplantation;Transplantation;2024-02-16
3. Delayed graft function: current status and future directions;Current Opinion in Organ Transplantation;2022-11-07
4. mTOR kinase is a therapeutic target for respiratory syncytial virus and coronaviruses;Scientific Reports;2021-12
5. Quantitative Assessment of Intraoperative Laser Fluorescence Angiography with Indocyanine Green Predicts Early Graft Function after Kidney Transplantation;Annals of Surgery;2020-12-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3